|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
 |
      |
|||||||||||||
 |
 |
|||||||||||||
   
 |
||||||||||||||
Thomas Koob, PhD
Chief Scientific Officer
Dr. Thomas Koob, our Chief Scientific Officer and the inventor on the patents that are the basis of the Company's license agreement with Shriners and the University of South Florida, received his Ph.D. in Biochemistry from Washington University School of Medicine in St. Louis. He completed four years of post-doctoral training at Harvard Medical School and four years of specialty training in the Laboratory of Skeletal Disorders, Department of Orthopaedics at Children's Hospital Medical Center in Boston. As Section Chief of Skeletal Biology at Shriners Hospital for Children in Tampa, a position he held for fourteen years, he developed and patented the Company's core technology. He has published over 125 biomedical and biological articles and 12 book chapters.
These statements have not been reviewed by the FDA.
This website is not meant as a substitute for professional medical advice.
|
|
 |
|
